Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
39.49 USD | +0.03% | +0.48% | -2.40% |
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Investment and Related Activities
100.0
%
| 21 | 100.0 % | 35 | 100.0 % | +62.93% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 21 | 100.0 % | 35 | 100.0 % | +62.93% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 31/12/10 | |
Trent Walker
DFI | Director of Finance/CFO | 50 | 31/12/20 |
Charles Park
CMP | Compliance Officer | 57 | 31/12/13 |
Janey Ahn
SEC | Corporate Secretary | 49 | 31/12/11 |
Jay M. Fife
TRE | Treasurer | 54 | 31/12/06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Frank Fabozzi
BRD | Director/Board Member | 76 | 31/12/06 |
W. Kester
BRD | Director/Board Member | 73 | 31/12/06 |
Chief Executive Officer | 60 | 31/12/10 | |
Cynthia Egan
BRD | Director/Board Member | 68 | 31/03/16 |
Robert Hubbard
CHM | Chairman | 66 | 31/12/06 |
Lorenzo Flores
BRD | Director/Board Member | 60 | 29/07/21 |
Rob Fairbairn
BRD | Director/Board Member | 59 | 15/02/18 |
James Holloman
BRD | Director/Board Member | 69 | 09/06/21 |
Catherine Lynch
BRD | Director/Board Member | 63 | 29/02/16 |
Stayce Harris
BRD | Director/Board Member | 65 | 09/06/21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 13,943,973 | 13,943,973 ( 100.00 %) | 0 | 100.00 % |
Company contact information
BlackRock Health Sciences Trust
100 Bellevue Parkway
19809, Wilmington
+212 810 5300
1st Jan change | Capi. | |
---|---|---|
-2.40% | 496M | |
+2.55% | 12.65B | |
+7.97% | 9.05B | |
+11.15% | 5.5B | |
-4.36% | 5.38B | |
+7.08% | 5.22B | |
+14.70% | 4.36B | |
+11.26% | 4.36B | |
+1.29% | 3.97B | |
+4.35% | 3.84B |
- Stock Market
- Equities
- BME Stock
- Company BlackRock Health Sciences Trust